AGEN-1571 | m-entrepreneurship.com

Product Name :
AGEN-1571

Search keywords :
LILRB1

drugId :
null

Target Vo:
Leukocyte immunoglobulin-like receptor B1

Target Vo Short Name :
LILRB1

Moa_Name:
Leukocyte immunoglobulin-like receptor B1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Agenus Inc

Active Company_Name :
Agenus Inc

Active Indication_Name:
Solid tumours

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Sotrovimab web
Anti-Mouse 4-1BB/CD137 Antibody (3H3) Apoptosis
Myogenin Antibody: Myogenin Antibody is an unconjugated, approximately 25 kDa, rabbit-derived, anti-Myogenin polyclonal antibody. Myogenin Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in (predicted) human, mouse, rat, pig, cow, horse, rabbit, sheep background without labeling.

Author: Betaine hydrochloride

Related Posts